CDT Equity Inc. (CDT) vs Psyence Biomedical Ltd. (PBM)
A side-by-side comparison of CDT Equity Inc. and Psyence Biomedical Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDT
CDT Equity Inc.
$0.88HealthcareDelayed quote: Oct 6, 2026, 3:08 PM EDT
PBM
Psyence Biomedical Ltd.
$5.00HealthcareDelayed quote: Oct 6, 2026, 3:01 PM EDT
Total return — CDT vs PBM
growth of $100 · dividends reinvested · last 3yCDT -100.0% (-99.7%/yr)PBM -100.0% (-93.3%/yr)PBM compounded faster over this window
Log scale — wide-divergence pair
CDT PBM
Metrics side by side
Total return (annualized)
| Metric | CDT | PBM |
|---|---|---|
| Total return (1Y) | N/A | -73.54% |
PBM is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.